Aethlon Medical (NASDAQ:AEMD – Get Free Report) will be announcing its earnings results after the market closes on Wednesday, November 13th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.44) by $0.10. During the same period in the previous year, the firm earned ($1.30) EPS.
Aethlon Medical Price Performance
Shares of NASDAQ AEMD opened at $0.38 on Thursday. The firm’s 50 day simple moving average is $0.39 and its 200-day simple moving average is $0.53. Aethlon Medical has a 12 month low of $0.24 and a 12 month high of $2.35. The stock has a market capitalization of $5.31 million, a price-to-earnings ratio of -0.10 and a beta of 1.74.
Analysts Set New Price Targets
Check Out Our Latest Research Report on Aethlon Medical
Aethlon Medical Company Profile
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Featured Articles
- Five stocks we like better than Aethlon Medical
- 3 REITs to Buy and Hold for the Long Term
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
- Industrial Products Stocks Investing
- Atlassian Is Up +60% in Three Months—What’s Causing the Rally?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 2 Reasons To Like Coinbase After The Election, 1 to Still Avoid
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.